Suchergebnisse - "Kim, Ha Il"

PubPharm (75)

1

Novel Tyrosine derivative

enthalten in: Europäisches Patentamt | 2023

von AHN JIN HEE | KIM MIN HEE | YOON JI HYEON | +4

2

Loco-regional therapies competing with radiofrequency ablation in potential indications for hepatocellular carcinoma : a network meta-analysis

enthalten in: Clinical and molecular hepatology | 2023

von Kim, H. | An, J. | Han, S. | +1

CommentIn: Clin Mol Hepatol. 2023 Oct;29(4):984-986. - PMID 37583053

3

Impact of metabolic risk factors on hepatic and cardiac outcomes in patients with alcohol- and non-alcohol-related fatty liver disease

enthalten in: JHEP reports : innovation in hepatology | 2023

von Lim, J. | Sang, H. | Kim, H.

4

Antioxidant and anti-inflammatory composition comprising extract of papaver plant

enthalten in: Europäisches Patentamt | 2023

von LEE SEOK GEUN | HA IN JIN | KIM HA IL

5

Antioxidant and anti-inflammatory composition comprising extract of papaver plant

enthalten in: Europäisches Patentamt | 2023

von LEE SEOK GEUN | HA IN JIN | KIM HA IL

6

Ranking of transarterial and targeted therapies for advanced hepatocellular carcinoma in the era of immuno-oncology : A network meta-analysis of randomized sorafenib-controlled trials

enthalten in: Hepatology communications | 2022

von An, J. | Han, S. | Kim, H. | +1

7

1 L- versus 2 L-polyethylene glycol with ascorbic acid for bowel preparation in elderly patients : a randomized multicenter study

enthalten in: Surgical endoscopy | 2022

von Yoon, J. | Kim, H. | Cho, Y. | +2

8

Role of the alpha-fetoprotein response in immune checkpoint inhibitor-based treatment of patients with hepatocellular carcinoma

enthalten in: Journal of cancer research and clinical oncology | 2022

von Kim, H. | Lim, J. | Shim, J.

9

Integrated prognostic and histogenomic justification of stage-directed therapy for single large hepatocellular carcinoma : a Korean nationwide registry study

enthalten in: Gut | 2022

von An, J. | Kim, H. | Oh, B. | +5

CommentOn: Gut. 2020 Oct;69(10):1893-1895. - PMID 31748202

10

PET-Based Radiogenomics Supports mTOR Pathway Targeting for Hepatocellular Carcinoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von An, J. | Oh, M. | Kim, S. | +9

1
2
3
4
5
6
7
8
Nächster »
[8]